Related Experiment Video
Updated: Jul 19, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Prognostic significance of hemoglobin level in patients with congestive heart failure and normal ejection fraction
Padmini Varadarajan1, Siddharth Gandhi, Sanjay Sharma
1Department of Medicine, Loma Linda University Medical Center, Loma Linda, California, USA.
Insights
Low hemoglobin (Hb) independently worsens survival in patients with congestive heart failure (CHF), regardless of left ventricular ejection fraction (EF). This finding highlights Hb as a critical prognostic factor in CHF management.
Area of Science:
- Cardiology
- Hematology
Background:
- Previous research indicates low hemoglobin (Hb) negatively impacts survival in congestive heart failure (CHF) patients with reduced left ventricular ejection fraction (EF).
- The prognostic significance of low Hb in CHF patients with preserved EF remains largely uninvestigated.
Purpose of the Study:
- To investigate the association between low Hb and survival in patients diagnosed with CHF and normal EF.
- To determine if low Hb is an independent predictor of mortality in CHF patients across different EF statuses.
Main Methods:
- A retrospective chart review of 2,246 CHF patients (48% with normal EF) diagnosed between 1990-1999.
- Diagnosis validation using Framingham criteria and mortality data from the National Death Index.
- Survival analysis conducted with Kaplan-Meier and Cox regression models, adjusting for multiple clinical variables.
Main Results:
- Low Hb (< 12 gm/dl) was significantly associated with decreased 5-year survival in both normal EF (38% vs. 50%) and reduced EF (35% vs. 48%) groups.
- Cox regression analysis identified low Hb as an independent predictor of mortality, even after adjusting for age, gender, renal dysfunction, diabetes, hypertension, and EF.
Conclusions:
- Low hemoglobin exerts an independent adverse effect on survival in patients with congestive heart failure.
- This adverse effect is consistent across patients with both normal and reduced left ventricular ejection fraction.
Background:
Previous studies have shown low hemoglobin (Hb) to have an adverse effect on survival in patients with congestive heart failure (CHF) and reduced left ventricular (LV) ejection fraction (EF); but its effect on survival in patients with CHF and normal EF is not known.
Hypothesis:
This study sought to determine whether low Hb has an effect on survival in patients with both CHF and normal EF.
Methods:
Detailed chart reviews were performed by medical residents on 2,246 patients (48% with normal EF) with a discharge diagnosis of CHF in a large tertiary care hospital from 1990 to 1999. The CHF diagnosis was validated using the Framingham criteria. Mortality data were obtained from the National Death Index. Survival analysis was performed using Kaplan-Meier and Cox regression models.
Results:
By Kaplan-Meier analysis, low Hb (< 12 gm/dl) compared with normal hemoglobin was associated with a lower 5-year survival in patients with CHF and both normal (38 vs. 50%, p = 0.0008) and reduced (35 vs. 48%, p = 0.0009) EF. Using the Cox regression model, low Hb was an independent predictor of mortality after adjusting for age, gender, renal dysfunction, diabetes mellitus, hypertension, and EF in both groups of patients.
Conclusion:
Low Hb has an independent adverse effect on survival in patients with CHF and both normal and reduced EF in both groups of patients.
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure II: Pathophysiology
Heart Failure VII: Nursing Interventions
Heart Failure V: Medical Management
Heart Failure I: Introduction